Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Scandinavian Pharmaceuticals-Generics Aktiebolag
AB
Active
Org 5562293794
Activities of holding companies
· NACE 6421
Est. 1983
0 employees
Watchlist
Share
Sweden
/
Companies
/
Activities of holding companies
/
Scandinavian Pharmaceuticals-Generics Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
—
—
—
—
—
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
0
0
0
0
0
Net financials
−1 763
−502
—
−8 260
−8 919
Profit before tax
−1 763
−502
0
−8 260
−8 919
Tax
−0
−0
−0
−0
−0
Net profit
−1 763
−502
0
−8 260
−8 919
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
202 369
202 348
202 348
202 348
202 348
Equity
10 255
9 754
8 034
−226
855
Long-term debt
182 114
182 594
194 313
202 574
201 492
Short-term debt
10 000
10 000
0
0
0
Total debt
192 114
192 594
194 313
202 574
201 492
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2020
2024
Equity ratio
0.4%
This company
38.2%
Market median
-99% vs market
2020
2024
Return on equity
-1043.2%
This company
18.4%
Market median
-5770% vs market
2020
2024
Net profit margin
-891900000.0%
This company
8.1%
Market median
-11011111211% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
235.66×
This company
0.62×
Market median
-37910% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Scandinavian Pharmaceuticals-Generics Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
